Fauci: ‘Three-Dose Regimen’ of Pfizer Vax for Infants and Toddlers is Coming

Young girl getting vaccine

The Biden administration is planning to recommend the experimental mRNA vaccines for babies as young as six months old, despite alarming safety signals and concerns that mass vaccination is making the pandemic worse.

White House chief medical adviser Dr. Anthony Fauci announced Wednesday that Pfizer vaccines for infants and toddlers are currently being tested, and once the shots are approved, a “three-dose regimen” will be recommended.

Read More

Texas Gov. Abbott Bans Vaccine Mandates Statewide Despite FDA Approval

Texas Gov. Greg Abbott on Wednesday banned government-issued vaccine mandates despite the Food and Drug Administration’s recent approval of Pfizer’s coronavirus vaccine.

Abbott’s executive order applies to all government-run entities with the exception of nursing homes and assisted living facilities. “Vaccine requirements and exemptions have historically been determined by the legislature, and their involvement is particularly important to avoid a patchwork of vaccine mandates across Texas,” Abbott said in an accompanying statement.

Read More

Vaccines Protect Against Multiple Variants, Additional Studies Suggest

Doctor with mask on holding COVID-19 Vaccine

The Pfizer and Moderna coronavirus vaccines are highly effective against and prevent illness from common variants of the virus, according to recently released studies.

The vaccine made by Pfizer is effective against the coronavirus variants that originated from the U.K. and South Africa, according to multiple studies released Wednesday that examined real-world vaccinations, The New York Times reported. Moderna reported that an early-stage trial suggested its vaccine is effective against the South African variant and a third variant originating from Brazil when given as a single-dose booster shot.

“At this point in time, we can confidently say that we can use this vaccine, even in the presence of circulating variants of concern,” London School of Hygiene and Tropical Medicine infectious disease researcher Annelies Wilder-Smith told the NYT.

Read More

Pfizer Says Its Vaccine Significantly Halts COVID-19’s Spread, Effective Against UK Variant

Pfizer said Wednesday that real-world data suggests its coronavirus vaccine is 94% effective in halting asymptomatic infections and effective against a highly transmissible variant first discovered in the United Kingdom.

Israeli analysis of vaccine distribution shows the vaccine being over 97% effective in preventing symptomatic cases and death, higher than the 90% efficiency that was reported in the vaccine’s Phase III trials, Pfizer said in a press release Thursday. Over 80% of the tested specimens were against the UK variant known as B.1.1.7.

Read More